Trials / Completed
CompletedNCT03390465
Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects
An Open-label, Randomized, Single Dose, 6-Sequence, 3-Period, Cross-over Study to Evaluate a Drug Interaction Between Fixed-dose Combination of Fimasartan/Amlodipine and Hydrochlorothiazide in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Boryung Pharmaceutical Co., Ltd · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the Drug interaction and safety of Fimasartan/Amlodipine and Hydrochlorothiazide in Healthy Male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fimasartan/Amlodipine combination drug, Hydrochlorothiazide | Fimasartan/Amlodipine combination drug, Hydrochlorothiazide |
Timeline
- Start date
- 2017-12-15
- Primary completion
- 2018-01-16
- Completion
- 2018-01-30
- First posted
- 2018-01-04
- Last updated
- 2018-08-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03390465. Inclusion in this directory is not an endorsement.